XML 32 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Note 11 - Stock-based Compensation
3 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
NOTE
11.
STOCK-BASED COMPENSATION
 
Stock Options
 
The Company has granted stock awards to eligible participants under its incentive plans. The stock awards include options to purchase the Company’s common stock. These stock options include a combination of service and market conditions, as further described below. 
 
For the
three
months ended
March 31, 2020
, the Company recognized
$0.1
 million in stock-based compensation for stock options and
$1.4
 million for restricted stock awards. For the
three
months ended 
March 31, 2019
, the Company recognized 
$0.2
million in stock-based compensation for stock options and 
$0.9
million for restricted stock awards. We recognize stock-based compensation on a straight-line basis over the vesting period for time based awards and we recognize the expense for awards with market conditions over the service period derived from the related valuation.
 
The amount of unrecognized compensation expense associated with stock options was
$0.7
 million and for restricted stock was
$10.3
 million at 
March 31, 2020
 which is expected to be recognized over a
1.8
and
2.6
yearly weighted average period, respectively.
 
The Company calculates the grant date fair value of stock options that vest over a service period using the Black Scholes model. For stock options that contain a market condition related to the return on investment that the Company’s stockholders achieve, the options are valued using a lattice-based option valuation model. The assumptions used in these calculations are the expected dividend yield, expected volatility, risk-free interest rate and expected term (in years). Expected volatilities are based on implied volatilities from comparable companies. The expected time to liquidity is based on Management’s estimate. The risk-free rate is based on the U.S. Treasury yield curve for a term equivalent to the estimated time to liquidity. There were
no
 options granted during the
three
months ended
March 31, 2020
.
 
Stock option awards represent options to purchase common stock and are granted pursuant to the Company’s incentive plans, and include options that the Company primarily classifies as Tranche A or time based, Tranche B and Tranche C.
 
Tranche A or time based options are eligible to vest in equal installments of
20%
or
25%
on each of the
first
five
or
four
anniversaries of the date of the grant, subject to continued employment with the Company or its subsidiaries. In the event of a termination of employment without cause or as a result of death or disability, any such time based options which would have vested on the next applicable vesting date shall become vested, and the remaining unvested time based options shall be forfeited. In addition, upon a Change in Control (as defined in the incentive plans), subject to continued employment through the date of the Change in Control, all outstanding unvested time based options shall immediately vest. An IPO does
not
qualify as a Change in Control as it relates to the vesting of stock options.
 
All other option awards are eligible to vest upon the satisfaction of certain performance conditions (collectively, “Performance Options”). These performance conditions included the achievement of investor returns or common stock trading prices. These performance conditions were achieved in
October
of
2018
for all Performance Options that have been granted and there are currently
595,621
Performance Options exercisable and outstanding.
 
A summary of the changes in stock options outstanding during the
three
months ended
March 31, 2020
, is as follows:
 
   
Number of Options
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contract Term (years)
   
Aggregate Intrinsic Value (in thousands)
 
Options outstanding as of December 31, 2019
   
1,382,986
    $
9.10
     
5.45
    $
4,793
 
Granted
   
-
     
-
     
-
     
-
 
Exercised
   
(15,544
)   $
10.15
     
 
     
 
 
Canceled or forfeited
   
(4,274
)   $
10.15
     
 
     
 
 
Options outstanding as of March 31, 2020
   
1,363,168
    $
9.08
     
5.04
    $
-
 
Options exercisable as of March 31, 2020
   
1,233,857
    $
8.54
     
4.80
    $
-
 
 
Restricted Stock
 
Restricted stock awards are typically eligible to vest in equal installments of
25%
on each of the
first
four
anniversaries of the date of the grant, subject to continued employment with the Company or its subsidiaries. In the event of a termination of employment without cause upon or within
12
months following a change in control or as a result of death or disability, any such unvested time based restricted stock awards shall become vested.
 
Certain restricted stock awards are eligible to vest upon the satisfaction of certain conditions (collectively, “Performance Awards”). Vesting occurs on the
first
day that the average price per share of our common stock for the prior 
60
 consecutive trading days exceeds certain stock prices.
 
A summary of the changes in restricted stock outstanding during the
three
months ended
March 31, 2020
, is as follows:
 
   
Shares Outstanding
   
Grant Date Fair Value (per share)
 
Restricted Stock Outstanding as of December 31, 2019
   
712,496
    $
23.66
 
Granted    
38,941
    $
10.45
 
Vested    
(75,565
)   $
23.84
 
Canceled or forfeited    
(23,199
)   $
24.74
 
Restricted stock outstanding as of March 31, 2020
   
652,673
    $
22.82